MEDNATION AG(FRA:EIF) stock Fundamental Analysis

Fundamental Rating

Taking everything into account, EIF scores 5 out of 10 in our fundamental rating. EIF was compared to 24 industry peers in the Health Care Providers & Services industry. EIF scores excellent on profitability, but there are some minor concerns on its financial health. EIF is valued correctly, but it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year EIF was profitable.

EIF had a positive operating cash flow in the past year.

In the past 5 years EIF reported 4 times negative net income.

Each year in the past 5 years EIF had a positive operating cash flow.

1.2 Ratios

With a decent Return On Assets value of 4.34%, EIF is doing good in the industry, outperforming 79.17% of the companies in the same industry.

With an excellent Return On Equity value of 26.01%, EIF belongs to the best of the industry, outperforming 95.83% of the companies in the same industry.

EIF has a better Return On Invested Capital (7.11%) than 83.33% of its industry peers.

		Industry Rank	Sector Rank
ROA	4.34%
ROE	26.01%
ROIC	7.11%

ROA(3y)-1.65%

ROA(5y)-1.59%

ROE(3y)-14.96%

ROE(5y)-11.92%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With an excellent Profit Margin value of 6.64%, EIF belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.

EIF has a Operating Margin of 13.53%. This is amongst the best in the industry. EIF outperforms 95.83% of its industry peers.

In the last couple of years the Operating Margin of EIF has grown nicely.

EIF has a Gross Margin of 82.96%. This is amongst the best in the industry. EIF outperforms 83.33% of its industry peers.

EIF's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	13.53%
PM (TTM)	6.64%
GM	82.96%

OM growth 3Y49.73%

OM growth 5Y95.02%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.01%

GM growth 5Y-0.44%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so EIF is still creating some value.

Compared to 1 year ago, EIF has about the same amount of shares outstanding.

EIF has about the same amout of shares outstanding than it did 5 years ago.

The debt/assets ratio for EIF has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 1.03, we must say that EIF is in the distress zone and has some risk of bankruptcy.

With a Altman-Z score value of 1.03, EIF perfoms like the industry average, outperforming 45.83% of the companies in the same industry.

EIF has a debt to FCF ratio of 3.92. This is a good value and a sign of high solvency as EIF would need 3.92 years to pay back of all of its debts.

The Debt to FCF ratio of EIF (3.92) is better than 79.17% of its industry peers.

EIF has a Debt/Equity ratio of 1.01. This is a high value indicating a heavy dependency on external financing.

EIF has a Debt to Equity ratio (1.01) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	1.01
Debt/FCF	3.92
Altman-Z	1.03

ROIC/WACC1.47

WACC4.85%

2.3 Liquidity

A Current Ratio of 1.11 indicates that EIF should not have too much problems paying its short term obligations.

EIF has a Current ratio of 1.11. This is in the better half of the industry: EIF outperforms 62.50% of its industry peers.

EIF has a Quick Ratio of 1.08. This is a normal value and indicates that EIF is financially healthy and should not expect problems in meeting its short term obligations.

EIF has a better Quick ratio (1.08) than 75.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.11
Quick Ratio	1.08

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 257.21% over the past year.

Looking at the last year, EIF shows a quite strong growth in Revenue. The Revenue has grown by 15.42% in the last year.

EIF shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.42% yearly.

EPS 1Y (TTM)257.21%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%156.41%

Revenue 1Y (TTM)15.42%

Revenue growth 3Y7.14%

Revenue growth 5Y-2.42%

Sales Q2Q%12.48%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 1.43 indicates a rather cheap valuation of EIF.

EIF's Price/Earnings ratio is rather cheap when compared to the industry. EIF is cheaper than 100.00% of the companies in the same industry.

The average S&P500 Price/Earnings ratio is at 28.10. EIF is valued rather cheaply when compared to this.

		Industry Rank	Sector Rank
PE	1.43
Fwd PE	N/A

4.2 Price Multiples

EIF's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. EIF is cheaper than 100.00% of the companies in the same industry.

100.00% of the companies in the same industry are more expensive than EIF, based on the Price/Free Cash Flow ratio.

		Industry Rank	Sector Rank
P/FCF	1.4
EV/EBITDA	1.59

4.3 Compensation for Growth

EIF has a very decent profitability rating, which may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for EIF!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

MEDNATION AG

FRA:EIF (5/5/2025, 7:00:00 PM)

1.46

+0.06 (+4.29%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)09-30 2024-09-30

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners25.13%

Ins Owner ChangeN/A

Market Cap4.56M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	1.43
Fwd PE	N/A
P/S	0.1
P/FCF	1.4
P/OCF	1.22
P/B	0.39
P/tB	0.39
EV/EBITDA	1.59

EPS(TTM)1.02

EY69.86%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)1.04

FCFY71.5%

OCF(TTM)1.2

OCFY82.21%

SpS14.82

BVpS3.79

TBVpS3.77

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	4.34%
ROE	26.01%
ROCE	10.1%
ROIC	7.11%
ROICexc	7.37%
ROICexgc	7.37%
OM	13.53%
PM (TTM)	6.64%
GM	82.96%
FCFM	7.04%

ROA(3y)-1.65%

ROA(5y)-1.59%

ROE(3y)-14.96%

ROE(5y)-11.92%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3Y55.71%

ROICexcg growth 5Y72.19%

ROICexc growth 3Y55.69%

ROICexc growth 5Y72.32%

OM growth 3Y49.73%

OM growth 5Y95.02%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.01%

GM growth 5Y-0.44%

F-Score8

Asset Turnover0.65

Health

		Industry Rank	Sector Rank
Debt/Equity	1.01
Debt/FCF	3.92
Debt/EBITDA	1.25
Cap/Depr	14.98%
Cap/Sales	1.06%
Interest Coverage	2.22
Cash Conversion	39.35%
Profit Quality	106.03%
Current Ratio	1.11
Quick Ratio	1.08
Altman-Z	1.03

F-Score8

WACC4.85%

ROIC/WACC1.47

Cap/Depr(3y)10.83%

Cap/Depr(5y)12.76%

Cap/Sales(3y)1.47%

Cap/Sales(5y)1.67%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)257.21%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%156.41%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)15.42%

Revenue growth 3Y7.14%

Revenue growth 5Y-2.42%

Sales Q2Q%12.48%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y397.39%

EBIT growth 3Y60.43%

EBIT growth 5Y90.31%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y9.66%

FCF growth 3Y-19.45%

FCF growth 5YN/A

OCF growth 1Y-5.74%

OCF growth 3Y-18.01%

OCF growth 5Y53.19%

MEDNATION AG (EIF.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens